© 2020 MJH Life Sciences and HCPLive. All rights reserved.
July 31, 2020
The expansion makes history for the injection biologic.
June 05, 2020
The findings are based on data from a 24-week observation from an ongoing phase 3 PATERA study.
May 20, 2020
There is no significant association between biologic exposure and the development of melanoma in patients with IBD, rheumatoid arthritis, or psoriasis.
May 08, 2020
Investigators found 30 mg of apremilast results in a significant reduction in plaque psoriasis patients.
May 06, 2020
An assessment of survey data show patients with severe depressive or psychological symptoms are more likely to be dissatisfied with their dermatologist.
May 05, 2020
A dermatologist discusses how to care for patients with psoriasis during the COVID-19 pandemic.
April 15, 2020
The IL-17A-targeting biologic has now been indicated for pediatric plaque psoriasis—marking its fourth indication for patients with chronic diseases.
April 08, 2020
New phase 3 IMMhance findings show durable, sustained effect of the IL-23 inhibitor on a 12-week dose regimen.
March 21, 2020
Lisa Stein Gold, MD, of Henry Ford Hospital discusses promising phase 2 data for a new PDE4 inhibitor.
February 24, 2020
Patients with psoriatic arthritis are not at an increased risk of cancer, however.